Posted by Michael Wonder on 17 Jan 2022
ATAGI update following weekly COVID-19 meeting (12 January 2022)
17 January 2022 - Previously, severely immunocompromised people aged 12 years and older were recommended to receive a third primary dose of COVID-19 vaccine to optimise their protection.
This recommendation has now been expanded to include severely immunocompromised children aged 5 to 11 years.
